about
The molecular mechanisms of the thrombotic complications of atherosclerosisMatrix Metalloproteinases in Non-Neoplastic Disorders.Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaqueSynthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesThe Roles of CD137 Signaling in AtherosclerosisDevelopment of selective inhibitors and substrate of matrix metalloproteinase-12.Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.Molecular imaging of atherosclerosis: a progress report.Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.Aggregation and fusion of low-density lipoproteins in vivo and in vitro.Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.Relationship of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability.Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κBPioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity.Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets.Cardiotrophin-1 induces matrix metalloproteinase-1 in human aortic endothelial cellsElectrophilic fatty acids regulate matrix metalloproteinase activity and expression.Caldesmon as a therapeutic target for proliferative vascular diseases.Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infectionThe LDL-HDL profile determines the risk of atherosclerosis: a mathematical model.Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation.Primary human monocyte differentiation regulated by Nigella sativa pressed oil.Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.Association Between High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C>T) Polymorphism in Patients With ST-Elevation Acute Myocardial InfarctionPivotal roles of monocytes/macrophages in strokeMatrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells.Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.Pentosan polysulfate inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbits: differential modulation of metalloproteinase-2 and -9Metalloproteinases and vulnerable atherosclerotic plaquesTLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis.The Degradome database: mammalian proteases and diseases of proteolysis.
P2860
Q24656816-E2C7381B-7A5F-460E-A7A7-AAED6F0542EEQ26741827-5D6F8C01-16AD-479E-833A-C8C45722FE89Q26824883-F34D9F0B-39E3-4A16-8395-5889EFBD319FQ27727742-7905F9DF-41C5-4C45-BB1E-966F0EEE6D61Q28076613-39D66647-713C-41CF-8EC5-A376FAF609A0Q33234060-16FDDC6F-0D54-405E-90BF-86A1564CE934Q33660754-8479363E-82E6-46AF-943F-2869523B5DBBQ33887957-F414ED74-CFB5-4EA7-BD0C-02E5E53B9C47Q33901989-C0338DE3-5999-4547-8CDE-127B46BD8484Q34068784-85D86902-8C50-4282-A702-AF602E9431DAQ34133240-44FD8FD2-73DA-47FA-A677-BFC9B66EE5AFQ34146262-23E87E52-E7EA-42B7-8DEC-24CDD6884B6BQ34161681-AC48A5C3-40FA-4AF1-B4FF-3BEA4EE93846Q34175955-7AE7EC75-B865-4084-9978-7E71F5235F01Q34374198-7A43AA4C-3747-455D-878F-2E2D7704B953Q34537454-C496F2EA-188C-4C63-AA98-9D7BFE6481B6Q34623513-D98F52EA-A08D-4507-BE56-DDB0A927A56CQ34636909-10ED39A3-3991-4921-A873-8CC2B58BB250Q34918559-C19249A2-7268-4ECC-9566-46B9C27220FDQ34963415-556760F2-E5C2-42A9-AC75-C26181AC94A3Q35065851-B94034D4-8803-430B-826A-1D8C558FA5AAQ35073899-9B51ECBE-74BF-4836-B78B-A4F3007BC724Q35118830-CF9BA54A-0B00-4F6B-A5D0-EFEE2CDDEA3CQ35152774-4685C29F-2AB0-483E-B979-F255ADC2A66EQ35607634-CF8E2CCC-A901-491F-B72C-7F582FB33E9AQ35761058-D5901484-1FE1-44CC-8095-ECCA861F20A6Q35986588-90F32593-4A1C-466F-86BD-4FA5129D23E1Q36009930-661643A7-0DF8-46AD-995D-1FE4183C7ADEQ36080941-AD27D24D-876B-46A1-950A-BDE6BEE41ADAQ36316432-638F7605-1AFF-4D4D-B031-4987126FD261Q36324756-08CA8FDD-E931-4735-A0B8-BFBC3DE6631EQ36599944-DD07E6C0-B170-47B8-ADC3-32614EF7DF43Q36644577-71D97AE6-5CA0-4428-89F7-D88DDD9C8C05Q36693179-F83FA304-20CC-4F99-B6E9-360E31691800Q36752100-75FDC12A-AFC3-440E-9CF8-4130974C2E8BQ36999082-98BB4BAD-D6A0-44CB-B1CC-84A6F8038A25Q37005370-570BA319-D4FB-447E-8C56-72BD84FCFB1EQ37166308-3F70668D-B68C-4067-9DE6-99E5131F360BQ37173216-A608D568-EDEF-445E-BABA-631C247DC547Q37202476-0E6B837C-3577-4553-A49D-3C225BA8A810
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Atherosclerosis and proteinase activation.
@ast
Atherosclerosis and proteinase activation.
@en
type
label
Atherosclerosis and proteinase activation.
@ast
Atherosclerosis and proteinase activation.
@en
prefLabel
Atherosclerosis and proteinase activation.
@ast
Atherosclerosis and proteinase activation.
@en
P1476
Atherosclerosis and proteinase activation.
@en
P2093
Clare M Dollery
P304
P356
10.1016/J.CARDIORES.2005.11.003
P50
P577
2005-12-22T00:00:00Z